6533b7ddfe1ef96bd1275251
RESEARCH PRODUCT
Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: A commentary
Federica MacalusoG. GugginoF. Cicciasubject
Multiple SclerosisRheumatologyAntirheumatic AgentsMultiple SclerosiImmunologyAntirheumatic AgentHumansImmunology and AllergySpondylitis AnkylosingAntibodies Monoclonal HumanizedHumandescription
No abstract available
year | journal | country | edition | language |
---|---|---|---|---|
2021-02-05 |